Primary Therapy for High Risk LQT Patients Should Be … Weiss - Primary...Primary Therapy for High...
Transcript of Primary Therapy for High Risk LQT Patients Should Be … Weiss - Primary...Primary Therapy for High...
Raul Weiss MD, FAHA, FACC, FHRS, CCDSDirector, Electrophysiology Fellowship Program
Associate Professor of MedicineThe Ohio State University
May 2011 HRS
Primary Therapy for High Risk LQT Patients Should Be an ICD
Disclosures • Educational and research support from Boston
Scientific, Medtronic, St Jude Medical, Biotronik, Biosense Webster, Gene Dx, Familion, Cameron Health and Stereotaxis
• Advisory Boards honoraria from Stereotaxis, Biosense Webster, Cameron Health and St Jude medical
• Speaker honoraria from St Jude Medical, Biotronik, Medtronic and Boston Scientific
• I will be discussing non FDA approved devices
Dr. London Did A Great Job Describing The ICD-Road-Ahead in LQTS Patients
But Let’s Get Closer…
Who Are The Patients At TheHighest Risk for SCD That an
ICD Should be Considered
Current ACC/AHA/ESC Guidelines for Implantable Cardioverter Defibrillator Prescription in long QT
Syndromes
• Class I: Implantation of an ICD along with the use of beta-blockers is recommended for LQTS patients with previous cardiac arrest (level of evidence: A)
• Class IIa: Implantation of an ICD with continued use of beta-blocker can be effective to reduce SCD in LQTS patients experiencing syncope and/or VT while receiving beta-blockers (level of evidence: B)
• Class IIb: Implantation of an ICD with the use of beta-blockers may be considered for prophylaxis of SCD for patients in categories possibly associated with higher risk of cardiac arrest such as LQT2 and LQT3 (level of evidence: B)
Rate of ACA or SCD by Genotype and QTc Category
Ilan Goldberg J Am Coll Cardiol 2011;57:51–9 (MODIFIED)
Age of 10 10%
24%
15%
4% 1%
Rate of ACA or SCD in PatientsWith Normal-Range QTc by Mutation Location
and Type
Ilan Goldberg J Am Coll Cardiol 2011;57:51–9
Cumulative Event-Free Survival For a First Appropriate ICD Shock According to Genotype
Schwartz, P. J. et al. Circulation 2010;122:1272-1282
Five-Year Cumulative Probability of ACA/SCD by Number of Syncopal
Events and QTc
Liu, J Am Coll Cardiol 2011;57:941–50)
Cumulative Event-Free Survival For a First Appropriate ICD Shock
Schwartz, P. J. et al. Circulation 2010;122:1272-1282 (modified)
By Corrected QT interval
By Risk Factors
ICD Reports in LTQS Patients
Schwartz, P. J. et al. Circulation 2010;122:1272-1282
Distribution of Patients at Implantation by Age and Gender
Cumulative Probability of Total Death in LQTS Pts with ACA or Recurrent
Syncope on ß-Blockers
Zareba, JCE,April 2003 Vol14,337-342
ICD In LQTS Patients
• Thirty-five LQTS Pts 75% ACA• Mean Age of 29 Y/o 83%F• 43% were Younger than 21 y/o• No deaths in 31 ± 21 months• 21 Pts with appropriate shocks
Groh et. al. AJC 1996;78:703-6
Summary of Individual and Cumulative ICD Risk Factor
Scorecard Elements Related to Appropriate ICD Therapies
Justin M. Horner Heart Rhythm 2010;7:1616–1622
*= p <0.05
Pros and Cons of ICD Over Medical Therapy
Pros• Highly effective• Compliance
– If you forget to take you BB– Diarrheal illnesses
• LQT-Prolonging Drug– Hypokalemia
• Family comfort/reassurance
Cons• Cost• Inappropriate therapies• Procedural complications• Long term complications
Pros and Cons of ICD Over Medical Therapy
Pros• Highly effective• Compliance
– If you forget to take you BB– Diarrheal illnesses
• LQT-Prolonging Drug– Hypokalemia
• Family comfort/reassurance
Cons• Cost• Inappropriate therapies• Procedural complications• Long term complications
Solutions• Longer detection times• Higher rate cut-off• Rate smoothing
• S-ICD• Increase battery longevity • Alert algorithms
ICD Utilization in The US in Patients Younger than 18 Y/O
Burns K. Heart Rhythm 2011;8:23–28
Hospital Data on ICD Implants on Patients <18 Years-old
Burns K. Heart Rhythm 2011;8:23–28
In Addition To Guidelines: ICD Should Be Considered in Pts With• LQTS patients with double mutations• Corrected QT of ≥500 msec and certainly if over ≥550 msec
• Congenital deafness• Patients that had a syncopal event regardless of the
QT duration• Genetically positive LQT 1 to 3 with
+Transmembrane-missense mutation• Family History is Not an indication for ICD
With Great Power Comes Great Responsibilities
Spiderman’s Uncle Ben
Thank you
Back up slides
What is the Problem?
Asymptomatic
SCD
Syncope
Liu, J Am Coll Cardiol 2011;57:941–50)
Risk Stratification
• Notably, women with the LQT2 genotype who experienced a first cardiac event exhibited an extremely high rate of subsequent events (58% during only 2 years of follow-up), further stressing the importance of careful follow-up and timely therapeutic intervention in this high-risk population
Liu, J Am Coll Cardiol 2011;57:941–50)
Liu, J Am Coll Cardiol 2011;57:941–50)
Liu, J Am Coll Cardiol 2011;57:941–50)
Liu, J Am Coll Cardiol 2011;57:941–50)
• How do you account to see of BB are working? Stress Test? HR? follow the QT? Assess for symptoms?
• How do you know your patient is taking the medication (compliance)
Distribution of QTc Interval Duration
in Genotype-Positive Patients With LQTS
Ilan Goldberg J Am Coll Cardiol 2011;57:51–9
Ilan Goldberg J Am Coll Cardiol 2011;57:51–9
Ilan Goldberg J Am Coll Cardiol 2011;57:51–9
Ilan Goldberg J Am Coll Cardiol 2011;57:51–9
Comparison of Clinical Characteristics of LQTS Patients With ACA Who Did and Did Not
Receive ICDs
Zareba, JCE,April 2003 Vol14,337-342
Zareba, JCE,April 2003 Vol14,337-342
Comparison of Clinical Characteristics of LQTS Pts With Recurrent Episode of
Syncope Despite BB Who Did and Did Not Receive an ICD
Zareba, JCE,April 2003 Vol14,337-342
Cumulative Probability of Total Death in LQTS Pts with ACA or Recurrent Syncope
on BB
Zareba, JCE,April 2003 Vol14,337-342
Incidence of ICD-Implant Related Complications
What if ICDs …
• Only shocks appropriately• Negligible risk of complication at initial
implant and/or during device change out
• Do not invade the intravascular space• Low cost ICD
• At 7.3 years of follow-up, more than 80% of those patients implanted with an ICD as primary prevention remained free of an appropriate discharge, compared with just 40% to 50% of those who received implantations for secondary prevention indications
Justin M. Horner Heart Rhythm 2010;7:1616–1622
• The most common reasons of inappropriate therapy overall were T-wave oversensing (35%) and sinus tachycardia (19%). The average supraventricular rate triggering inappropriate therapies was 207 beats/min.
Justin M. Horner Heart Rhythm 2010;7:1616–1622
Asymptomatic Patients: Absolute Event Rates for SCD According to genotype and
QTc• LQT1 0.3%/y (M: 0.33%, F 0.28%)• LQT2 0.6%/y (M: 0.46%, F: 0.82%)• LQT3 0.56%/y (M: 0.96%, F: 0.30%)• QTc was particularly relevant, with a QTc of
500–549 ms (vs. ,499 ms) associated with an HR of 3.34, and a QTc interval of .550 ms (vs. ,499) contributed an HR of 6.35. Moreover,
• QTc interval ,499 ms was found not to contribute independently to an increased risk of a lethal event (compared with a QTc interval ,439 ms)
Individual/cumulative risk factors and likelihood of an appropriate VF-terminating ICD therapy
Justin M. Horner Heart Rhythm 2010;7:1616–1622
Comparison of Clinical Characteristics of LQTS Pts With Recurrent Episode of
Syncope Despite BB Who Did and Did Not Receive an ICD
Zareba, JCE,April 2003 Vol14,337-342